Ina Haendle

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

Beatrice Thurner, Ina Haendle, Claudia Röder et al. · The Journal of Experimental Medicine · 1999 · 1.2K citations · Full text

Medicine, Immunology, Oncology +17

Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells

Beatrice Schuler-Thurner, Detlef Dieckmann, Petra Keikavoussi et al. · The Journal of Immunology · 2000 · 202 citations · Full text

Medicine, Immunology, Oncology +17

A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use

Bernadette Feuerstein, Thomas Berger, Christian Maczek et al. · Journal of Immunological Methods · 2000 · 159 citations

Life Sciences, Cell Biology, Immunology +16

Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients

Michael Erdmann, Ina Haendle, Steve Voland et al. · JCI Insight · 2017 · 85 citations · Full text

Medicine, Immunology, Oncology +17

Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg

Andreas S. Baur, Manfred B. Lutz, Stephan Schierer et al. · Blood · 2013 · 63 citations · Full text

Life Sciences, Cell Biology, Immunology +15